Live Breaking News & Updates on Study Evaluating Efficacy

Stay updated with breaking news from Study evaluating efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Positive Data Demonstrates Gepotidacin is Non-Inferior to Alternative Treatment in GC

In a trial that compared gepotidacin to ceftriaxone plus azithromycin in patients with urogenital gonorrhea, gepotidacin presented a 92.6% microbiological success rate. ....

Comunidad Autonoma De Cataluna , Chris Corsico , European Society Of Clinical Microbiology , European Congress , Study Evaluating Efficacy , Uncomplicated Urogenital , European Society , Clinical Microbiology , Infectious Diseases Global , Infectious Diseases ,

Gepotidacin Demonstrates Non-Inferiority Treating Uncomplicated Urogenital Gonorrhea in Phase 3 Trial

Gepotidacin was compared with the combination of ceftriaxone and azithromycin in adolescent and adult patients with uncomplicated urogenital gonorrhea. ....

Chris Corsico , Antibacterial Gepotidacin Evaluated , Open Label Study , Adult Participants Comparing , Ceftriaxone Plus Azithromycin , Uncomplicated Urogenital Gonorrhea Caused , Evaluate Efficacy , Uncomplicated Urinary Tract Infection , Comparative Study , Study Evaluating Efficacy , Uncomplicated Urogenital Gonorrhea Clinicaltrials ,